Publication | Closed Access

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

VaccinationVaccine SafetyHealthy AdolescentsPhase 2B/3Placebo-controlled StudyVaccine EfficacyInfection ControlPublic HealthBacterial MeningitisMedicineVaccine ResearchVaccine Hesitancy